Filing Details
- Accession Number:
- 0001209191-14-054713
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-08-27 18:03:24
- Reporting Period:
- 2014-08-25
- Filing Date:
- 2014-08-27
- Accepted Time:
- 2014-08-27 18:03:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1059790 | Pozen Inc | POZN | Pharmaceutical Preparations (2834) | 621657552 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1208290 | E John Barnhardt | C/O Pozen Inc. 1414 Raleigh Road, Suite 400 Chapel Hill NC 27517 | Vp, Finance And Administration | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-08-25 | 222 | $4.64 | 42,543 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-08-25 | 222 | $8.25 | 42,321 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2014-08-25 | 4,071 | $1.98 | 46,392 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-08-25 | 4,071 | $8.25 | 42,321 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | Disposition | 2014-08-25 | 222 | $0.00 | 222 | $4.64 |
Common Stock | Stock Option | Disposition | 2014-08-25 | 4,071 | $0.00 | 4,071 | $1.98 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2019-03-13 | No | 4 | M | Direct | |
0 | 2021-10-03 | No | 4 | M | Direct |
Footnotes
- Stock option exercise and open market sales pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- The options vested in four equal annual installments, with the initial vesting date occurring on March 13, 2010.
- The options vested in three equal installments upon the achievement of certain performance criteria.